Industry
Royalty Pharma Increases Bid For Elan to US$8 Billion
Royalty Pharma raised its hostile bid for Irish drug firm, Elan from US$12.50 to US$13. (Photo : Reuters)The image is the corporate logo of Royalty Pharma, the healthcare focused equity fund.
SoftBank Looks Into “Plan B” with Deutsche Telekom
SoftBank is in talks with Deutsche Telekom in possibly acquiring T-Mobile USA after Dish Network Corp. made counter offer for Sprint Nextel.
Chinese Regulatory Authorities Unveil New IPO Rules
China's regulatory watchdog has unveiled new IPO rules. Last Friday, the Chinese government had published new draft rules designed to improve the transparency and pricing structure of initial public offers in its domestic stock markets.
Credit Suisse Plans to Sell Off Assets to Focus on High End Markets
Credit Suisse is shunning low yield, high number moderately rich segment for high yield, low number ultra rich market segment.




